BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Camrelizumab
1
Association of triglyceride-glucose index with long-term prognosis in advanced hepatocellular carcinoma patients receiving immunotherapy and targeted therapy
8/7/2025 6:39:58 AM | Browse: 104 | Download: 238
2
Advanced pancreatic cancer treated with camrelizumab combined with apatinib: A case report
1/18/2025 8:12:11 AM | Browse: 94 | Download: 498
3
Five-year complete remission of super-giant hepatocellular carcinoma with hepatectomy followed by sorafenib plus camrelizumab: A case report
12/27/2024 1:37:06 PM | Browse: 133 | Download: 605
4
TRIPLET combined with microwave ablation: A novel treatment for advanced hepatocellular carcinoma
12/12/2024 9:30:52 AM | Browse: 166 | Download: 477
5
Dermatitis bullosa caused by the immune checkpoint inhibitor camrelizumab: A case report
12/4/2024 8:24:11 AM | Browse: 134 | Download: 605
6
Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy
9/26/2024 8:22:28 AM | Browse: 119 | Download: 605
7
Impact of baseline hepatitis B virus viral load on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy
6/15/2024 2:49:03 AM | Browse: 172 | Download: 931
8
Vedolizumab in the treatment of immune checkpoint inhibitor-induced colitis: Two case reports
9/29/2022 9:17:29 AM | Browse: 547 | Download: 1379
9
Camrelizumab-induced anaphylactic shock in an esophageal squamous cell carcinoma patient: A case report and review of literature
6/17/2022 3:19:27 AM | Browse: 440 | Download: 1551
10
Successful response to camrelizumab in metastatic bladder cancer: A case report
12/30/2021 8:21:53 AM | Browse: 572 | Download: 1250
11
Camrelizumab (SHR-1210) leading to reactive capillary hemangioma in gingiva: A case report
2/6/2020 2:37:44 AM | Browse: 747 | Download: 1447
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345